BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 28572589)

  • 1. Oncopig Soft-Tissue Sarcomas Recapitulate Key Transcriptional Features of Human Sarcomas.
    Schachtschneider KM; Liu Y; Mäkeläinen S; Madsen O; Rund LA; Groenen MAM; Schook LB
    Sci Rep; 2017 Jun; 7(1):2624. PubMed ID: 28572589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-152 down-regulation is associated with MET up-regulation in leiomyosarcoma and undifferentiated pleomorphic sarcoma.
    Pazzaglia L; Novello C; Conti A; Pollino S; Picci P; Benassi MS
    Cell Oncol (Dordr); 2017 Feb; 40(1):77-88. PubMed ID: 27900663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual Pten/Tp53 suppression promotes sarcoma progression by activating Notch signaling.
    Guijarro MV; Dahiya S; Danielson LS; Segura MF; Vales-Lara FM; Menendez S; Popiolek D; Mittal K; Wei JJ; Zavadil J; Cordon-Cardo C; Pandolfi PP; Hernando E
    Am J Pathol; 2013 Jun; 182(6):2015-27. PubMed ID: 23708211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines.
    Salawu A; Fernando M; Hughes D; Reed MW; Woll P; Greaves C; Day C; Alhajimohammed M; Sisley K
    Br J Cancer; 2016 Oct; 115(9):1058-1068. PubMed ID: 27560552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
    Francis P; Namløs HM; Müller C; Edén P; Fernebro J; Berner JM; Bjerkehagen B; Akerman M; Bendahl PO; Isinger A; Rydholm A; Myklebost O; Nilbert M
    BMC Genomics; 2007 Mar; 8():73. PubMed ID: 17359542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights in sarcoma oncogenesis: a comprehensive analysis of a large series of 160 soft tissue sarcomas with complex genomics.
    Gibault L; Pérot G; Chibon F; Bonnin S; Lagarde P; Terrier P; Coindre JM; Aurias A
    J Pathol; 2011 Jan; 223(1):64-71. PubMed ID: 21125665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.
    Pollack SM; He Q; Yearley JH; Emerson R; Vignali M; Zhang Y; Redman MW; Baker KK; Cooper S; Donahue B; Loggers ET; Cranmer LD; Spraker MB; Seo YD; Pillarisetty VG; Ricciotti RW; Hoch BL; McClanahan TK; Murphy E; Blumenschein WM; Townson SM; Benzeno S; Riddell SR; Jones RL
    Cancer; 2017 Sep; 123(17):3291-3304. PubMed ID: 28463396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic re-expression of HIF-2α suppresses soft tissue sarcoma growth.
    Nakazawa MS; Eisinger-Mathason TS; Sadri N; Ochocki JD; Gade TP; Amin RK; Simon MC
    Nat Commun; 2016 Feb; 7():10539. PubMed ID: 26837714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory investigation, genetics, and experimental models in sarcomas.
    Fletcher JA
    Curr Opin Oncol; 1991 Aug; 3(4):665-70. PubMed ID: 1932225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proteomic landscape of soft tissue sarcomas.
    Burns J; Wilding CP; Krasny L; Zhu X; Chadha M; Tam YB; Ps H; Mahalingam AH; Lee ATJ; Arthur A; Guljar N; Perkins E; Pankova V; Jenks A; Djabatey V; Szecsei C; McCarthy F; Ragulan C; Milighetti M; Roumeliotis TI; Crosier S; Finetti M; Choudhary JS; Judson I; Fisher C; Schuster EF; Sadanandam A; Chen TW; Williamson D; Thway K; Jones RL; Cheang MCU; Huang PH
    Nat Commun; 2023 Jun; 14(1):3834. PubMed ID: 37386008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A validated, transitional and translational porcine model of hepatocellular carcinoma.
    Schachtschneider KM; Schwind RM; Darfour-Oduro KA; De AK; Rund LA; Singh K; Principe DR; Guzman G; Ray CE; Ozer H; Gaba RC; Schook LB
    Oncotarget; 2017 Sep; 8(38):63620-63634. PubMed ID: 28969016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of heterogeneity among soft tissue sarcomas by gene expression profiles from different tumors.
    Skubitz KM; Pambuccian S; Manivel JC; Skubitz AP
    J Transl Med; 2008 May; 6():23. PubMed ID: 18460215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons from genetic profiling in soft tissue sarcomas.
    Nilbert M; Meza-Zepeda LA; Francis P; Berner JM; Namløs HM; Fernebro J; Myklebost O
    Acta Orthop Scand Suppl; 2004 Apr; 75(311):35-50. PubMed ID: 15188664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of p16(INK4a) is associated with reduced patient survival in soft tissue tumours, and indicates a senescence barrier.
    Knösel T; Altendorf-Hofmann A; Lindner L; Issels R; Hermeking H; Schuebbe G; Gibis S; Siemens H; Kampmann E; Kirchner T
    J Clin Pathol; 2014 Jul; 67(7):592-8. PubMed ID: 24747207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Concepts in Non-Gastrointestinal Stromal Tumor Soft Tissue Sarcomas: A Primer for Radiologists.
    Baheti AD; Jagannathan JP; O'Neill A; Tirumani H; Tirumani SH
    Korean J Radiol; 2017; 18(1):94-106. PubMed ID: 28096721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-omics analysis of copy number variations of RNA regulatory genes in soft tissue sarcoma.
    Wang X; Han Y; Li J; Hong D; Xue Z; Huang H; Du Z; Hou Y; Li H; Li H; Liao H; Xie X; Ding C
    Life Sci; 2021 Jan; 265():118734. PubMed ID: 33166590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of cancer-related genes in soft tissue sarcomas: hypermethylation of RASSF1A is frequently detected in leiomyosarcoma and associated with poor prognosis in sarcoma.
    Seidel C; Bartel F; Rastetter M; Bluemke K; Wurl P; Taubert H; Dammann R
    Int J Cancer; 2005 Apr; 114(3):442-7. PubMed ID: 15551306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and epigenetic alterations of the PTEN gene in soft tissue sarcomas.
    Kawaguchi K; Oda Y; Saito T; Takahira T; Yamamoto H; Tamiya S; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2005 Apr; 36(4):357-63. PubMed ID: 15891996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Fibroblast Growth Factor Receptor 1 for Treatment of Soft-Tissue Sarcoma.
    Chudasama P; Renner M; Straub M; Mughal SS; Hutter B; Kosaloglu Z; Schweßinger R; Scheffler M; Alldinger I; Schimmack S; Persigehl T; Kobe C; Jäger D; von Kalle C; Schirmacher P; Beckhaus MK; Wolf S; Heining C; Gröschel S; Wolf J; Brors B; Weichert W; Glimm H; Scholl C; Mechtersheimer G; Specht K; Fröhling S
    Clin Cancer Res; 2017 Feb; 23(4):962-973. PubMed ID: 27535980
    [No Abstract]   [Full Text] [Related]  

  • 20. Proteomic profiling of soft tissue sarcomas with SWATH mass spectrometry.
    Milighetti M; Krasny L; Lee ATJ; Morani G; Szecsei C; Chen Y; Guljar N; McCarthy F; Wilding CP; Arthur A; Fisher C; Judson I; Thway K; Cheang MCU; Jones RL; Huang PH
    J Proteomics; 2021 Jun; 241():104236. PubMed ID: 33895336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.